| Literature DB >> 22491464 |
Takushi Nomura1, Hiroyuki Yamamoto, Teiichiro Shiino, Naofumi Takahashi, Taku Nakane, Nami Iwamoto, Hiroshi Ishii, Tetsuo Tsukamoto, Miki Kawada, Saori Matsuoka, Akiko Takeda, Kazutaka Terahara, Yasuko Tsunetsugu-Yokota, Naoko Iwata-Yoshikawa, Hideki Hasegawa, Tetsutaro Sata, Taeko K Naruse, Akinori Kimura, Tetsuro Matano.
Abstract
Nonhuman primate AIDS models are essential for the analysis of AIDS pathogenesis and the evaluation of vaccine efficacy. Multiple studies on human immunodeficiency virus and simian immunodeficiency virus (SIV) infection have indicated the association of major histocompatibility complex class I (MHC-I) genotypes with rapid or slow AIDS progression. The accumulation of macaque groups that share not only a single MHC-I allele but also an MHC-I haplotype consisting of multiple polymorphic MHC-I loci would greatly contribute to the progress of AIDS research. Here, we investigated SIVmac239 infections in four groups of Burmese rhesus macaques sharing individual MHC-I haplotypes, referred to as A, E, B, and J. Out of 20 macaques belonging to A(+) (n = 6), E(+) (n = 6), B(+) (n = 4), and J(+) (n = 4) groups, 18 showed persistent viremia. Fifteen of them developed AIDS in 0.5 to 4 years, with the remaining three at 1 or 2 years under observation. A(+) animals, including two controllers, showed slower disease progression, whereas J(+) animals exhibited rapid progression. E(+) and B(+) animals showed intermediate plasma viral loads and survival periods. Gag-specific CD8(+) T-cell responses were efficiently induced in A(+) animals, while Nef-specific CD8(+) T-cell responses were in A(+), E(+), and B(+) animals. Multiple comparisons among these groups revealed significant differences in survival periods, peripheral CD4(+) T-cell decline, and SIV-specific CD4(+) T-cell polyfunctionality in the chronic phase. This study indicates the association of MHC-I haplotypes with AIDS progression and presents an AIDS model facilitating the analysis of virus-host immune interaction.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22491464 PMCID: PMC3393527 DOI: 10.1128/JVI.07077-11
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103